Avana
$ 112,00 – $ 419,00Price range: $ 112,00 through $ 419,00
Avodart
$ 40,00 – $ 556,00Price range: $ 40,00 through $ 556,00
Avandia
$ 113,00 – $ 824,00Price range: $ 113,00 through $ 824,00
Avandia is an oral medication specifically designed to help adults manage type 2 diabetes. This treatment works by increasing the body’s sensitivity to insulin, which helps regulate blood sugar levels more effectively. By improving how the body uses natural insulin, the medication aids in achieving better glycemic control over time. It is typically used in conjunction with a proper diet and exercise program to optimize health outcomes. Consistent use of this medication helps maintain stable glucose levels and supports long-term metabolic health.
Active substance: Rosiglitazone
SKU:
Avandia
Category: Diabetes
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Avandia (rosiglitazone maleate) belongs to a class of oral antidiabetic agents known as thiazolidinediones. It is approved by the U.S. Food and Drug Administration (FDA) as an adjunct to diet and exercise to improve glycemic control in adults diagnosed with type 2 diabetes mellitus.
As a prescription-only (Rx) medication, Avandia must be evaluated and managed by a licensed healthcare provider in accordance with federal regulations. This pharmaceutical agent is not indicated for treating type 1 diabetes mellitus or diabetic ketoacidosis.
Clinical Pharmacology and Prescribing Information
Mechanism of Action
Rosiglitazone functions as a selective agonist at the peroxisome proliferator-activated receptor-gamma (PPAR-γ), a nuclear receptor expressed predominantly in adipose tissue, skeletal muscle, and hepatic tissue. Activation of PPAR-γ alters the transcription of multiple insulin-responsive genes involved in glucose production, transport, and utilization. By binding to these receptors, rosiglitazone enhances peripheral tissue sensitivity to insulin rather than stimulating additional endogenous insulin secretion from pancreatic beta cells. Consequently, glycemic control improves as peripheral glucose uptake increases and hepatic glucose output is reduced.
Pharmacokinetics
Following oral administration, rosiglitazone exhibits high absolute bioavailability of approximately 99%. Peak plasma concentrations are achieved within approximately 1 hour post-dose. Plasma protein binding is extensive, measuring approximately 99.8%, primarily to albumin. Rosiglitazone is extensively metabolized in the liver via N-demethylation and hydroxylation, mediated predominantly by the cytochrome P450 CYP2C8 isoenzyme, with minor contributions from CYP2C9. The mean terminal elimination half-life ranges from 3 to 4 hours. Excretion occurs primarily via the urine (approximately 64%) and feces (approximately 23%) as metabolites, with negligible unchanged drug recovered.
Indications and Clinical Use
Avandia is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Clinical practice supports its administration as monotherapy or in combination with other oral antihyperglycemic agents, such as metformin or a sulfonylurea, when single-agent therapy fails to achieve adequate glycemic targets.
Off-label consideration: While rosiglitazone has been evaluated in non-approved clinical research settings–such as non-alcoholic fatty liver disease (NAFLD) or polycystic ovary syndrome (PCOS)–these applications are considered off-label and lack explicit FDA endorsement for routine clinical use.
Dosage and Administration
The management of type 2 diabetes with Avandia requires individualized dosing determined by a qualified prescriber. The recommended starting dose is typically 4 mg daily, administered either as a single dose in the morning or divided into 2 mg twice daily. If glycemic control remains inadequate after 8 to 12 weeks of therapy, the dosage may be titrated up to a maximum recommended dose of 8 mg daily (administered as 8 mg once daily or 4 mg twice daily). The medication may be taken with or without food. Dosage adjustments are not generally required based solely on advanced age or mild-to-moderate renal impairment, though careful clinical monitoring remains standard practice.
Safety Profile and Patient Considerations
Important Precautions and Boxed Warnings
Thiazolidinediones, including rosiglitazone, carry significant clinical precautions regarding fluid retention and cardiovascular function. Rosiglitazone can cause or exacerbate congestive heart failure. Initiation of Avandia is contraindicated in patients with established New York Heart Association (NYHA) Class III or IV heart failure. Prior to initiating therapy, healthcare providers assess patients for signs and symptoms of heart failure, including excessive weight gain, peripheral edema, and dyspnea. Additionally, liver function tests (serum transaminases) should be evaluated prior to initiation and periodically thereafter based on clinical judgment. Therapy should not be initiated if baseline serum ALT levels exceed 2.5 times the upper limit of normal.
Adverse Reactions
Adverse events documented during clinical trials of rosiglitazone include dose-related peripheral edema and fluid retention, which may increase the risk of heart failure. Mild-to-moderate weight gain is commonly observed, resulting from both fluid accumulation and fat tissue accumulation. Anemia (reduction in hemoglobin and hematocrit) may occur, largely secondary to hemodilution. Dose-dependent hypoglycemia may occur, particularly when rosiglitazone is co-administered with sulfonylureas or insulin. Clinical data also indicate an increased incidence of bone fractures in female patients receiving long-term thiazolidinedione therapy, predominantly affecting distal upper and lower limbs.
Drug Interactions
Co-administration of rosiglitazone with strong CYP2C8 inhibitors, such as gemfibrozil, significantly increases plasma concentrations of rosiglitazone, requiring a dose reduction (typically capped at 2 mg to 4 mg daily). Conversely, co-administration with CYP2C8 inducers, such as rifampin, can markedly decrease rosiglitazone plasma concentrations, potentially compromising therapeutic efficacy. Combining rosiglitazone with insulin increases the incidence of edema and heart failure; close clinical supervision is required if combination therapy is implemented. Concurrent use with sulfonylureas requires careful titration to minimize the risk of hypoglycemia.
What to Avoid While Taking It
Patients receiving Avandia should be counseled regarding dietary and alcohol intake. While the tablet may be ingested independently of meals, dietary compliance remains essential for overall glycemic control. Alcohol consumption should be limited, as alcohol can alter blood glucose regulation and increase the risk of hypoglycemia. Furthermore, heavy alcohol use may place additional stress on hepatic metabolism, complicating liver function monitoring.
Red Flags and Emergency Indicators
Immediate medical evaluation is warranted if patients experience signs indicative of acute cardiac or hepatic complications. Patients should contact emergency services or seek immediate care if they notice rapid, unexplained weight gain, severe swelling in the lower extremities, sudden onset of shortness of breath (especially when lying flat), chest pain, or symptoms of hepatic impairment such as dark urine, persistent nausea, abdominal pain, or yellowing of the skin and eyes (jaundice).
If You Skip a Dose
If a patient misses a scheduled dose of Avandia, the dose should be taken as soon as remembered on the same day. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely, and the regular dosing schedule resumed. Patients must not double the dose to make up for a missed tablet, as this increases the risk of adverse reactions and hypoglycemic events.
Pregnancy, Breastfeeding, and Special Populations
Rosiglitazone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus; insulin is generally preferred for managing diabetes during pregnancy. It is unknown whether rosiglitazone is excreted in human milk; caution is advised when administered to nursing mothers. Safety and effectiveness in pediatric patients under 18 years of age have not been established. Elderly patients require careful evaluation of cardiac function prior to and during treatment due to the increased baseline prevalence of heart disease in this demographic.
| Property | Details |
|---|---|
| Drug Name | Avandia |
| Active Ingredient | Rosiglitazone maleate |
| Therapeutic Class | Thiazolidinedione (Antidiabetic agent) |
| Dosage Form | Oral tablet (2 mg, 4 mg, 8 mg) |
| Route of Administration | Oral |
| Primary Purpose | Glycemic control in type 2 diabetes mellitus |
| Prescription Status | Prescription (Rx) only |
| Storage | Store at 20°C to 25°C (68°F to 77°F); light-resistant container |
Common Questions
Does Avandia cause weight gain?
Yes, clinical trials demonstrate that weight gain can occur during rosiglitazone treatment. This weight increase is typically dose-related and stems from a combination of fluid retention and adipose tissue distribution alterations.
Can Avandia be taken alongside insulin?
While combined use has been studied, co-administration of rosiglitazone and insulin significantly increases the risk of peripheral edema and congestive heart failure. Healthcare providers evaluate individual risk profiles before initiating this combination.
Is regular liver enzyme testing necessary?
Yes, baseline liver function tests (specifically serum ALT) are recommended before starting Avandia. Periodic monitoring is performed thereafter if clinically indicated or if symptoms of hepatic dysfunction arise.
How long does it take for Avandia to show full therapeutic effect?
While peak plasma concentration occurs within one hour of administration, maximal reduction in blood glucose levels generally requires 8 to 12 weeks of consistent daily administration due to its mechanism of modifying gene transcription.
What should be done if ankle swelling occurs?
Edema is a recognized adverse effect of rosiglitazone. Patients who observe swelling in their feet, ankles, or lower legs should inform their prescribing physician promptly for evaluation of fluid status and cardiovascular function.
Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.
In accordance with FDA requirements.
Additional information
| Dosage |
2 mg ,4 mg |
|---|---|
| Package |
60 pills ,100 pills ,200 pills ,240 pills ,400 pills |
| Ενεργός Ουσία |
Related products
Actoplus Met
$ 43,00 – $ 343,00Price range: $ 43,00 through $ 343,00
Active substance: metformin, Pioglitazone
More Details
This product has multiple variants. The options may be chosen on the product page
Dapasmart
$ 67,00 – $ 575,00Price range: $ 67,00 through $ 575,00
Active substance: Dapagliflozin
More Details
This product has multiple variants. The options may be chosen on the product page
DDAVP spray
$ 64,00 – $ 412,00Price range: $ 64,00 through $ 412,00
Active substance: Desmopressin acetate
More Details
This product has multiple variants. The options may be chosen on the product page
Diabecon
$ 57,00 – $ 345,00Price range: $ 57,00 through $ 345,00
Active substance: Diabecon
More Details
This product has multiple variants. The options may be chosen on the product page
Glucotrol XL
$ 14,00 – $ 170,00Price range: $ 14,00 through $ 170,00
Active substance: Glipizide
More Details
This product has multiple variants. The options may be chosen on the product page
Onglyza
$ 63,00 – $ 504,00Price range: $ 63,00 through $ 504,00
Active substance: Saxagliptin
More Details
This product has multiple variants. The options may be chosen on the product page
Prandin
$ 40,00 – $ 858,00Price range: $ 40,00 through $ 858,00
Active substance: Repaglinide
More Details
This product has multiple variants. The options may be chosen on the product page
Victoza
$ 450,00 – $ 850,00Price range: $ 450,00 through $ 850,00
Active substance: Liraglutide
More Details
This product has multiple variants. The options may be chosen on the product page
